【24h】

Iridoids as DNA topoisomerase I poisons.

机译:Iridoids是DNA拓扑异构酶I的毒物。

获取原文
获取原文并翻译 | 示例
           

摘要

The discovery of new topoisomerase I inhibitors is necessary since most of the antitumor drugs are targeted against type II and only a very few can specifically affect type I. Topoisomerase poisons generate toxic DNA damage by stabilization of the covalent DNA-topoisomerase cleavage complex and some have therapeutic efficacy in human cancer. Two iridoids, aucubin and geniposide, have shown antitumoral activities, but their activity against topoisomerase enzymes has not been tested. Here it was found that both compounds are able to stabilize covalent attachments of the topoisomerase I subunits to DNA at sites of DNA strand breaks, generating cleavage complexes intermediates so being active as poisons of topoisomerase I, but not topoisomerase II. This result points to DNA damage induced by topoisomerase I poisoning as one of the possible mechanisms by which these two iridoids have shown antitumoral activity, increasing interest in their possible use in cancer chemoprevention and therapy.
机译:必须发现新的拓扑异构酶I抑制剂,因为大多数抗肿瘤药物都针对II型,而且只有极少数能特异性地影响I型。拓扑异构酶毒物通过稳定共价DNA-拓扑异构酶裂解复合物而产生毒性DNA损伤。在人类癌症中的治疗功效。两种鸢尾碱,奥古宾和and子苷,已显示出抗肿瘤活性,但尚未测试它们对拓扑异构酶的活性。在此发现,这两种化合物都能够稳定拓扑异构酶I亚基在DNA链断裂位点与DNA的共价连接,生成裂解复合物中间体,因此具有拓扑异构酶I(而非拓扑异构酶II)的毒性。该结果表明由拓扑异构酶I中毒引起的DNA损伤是这两种类环烯类化合物显示出抗肿瘤活性的可能机制之一,从而增加了对其在癌症化学预防和治疗中的用途的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号